November 4th 2022
Medical experts highlight key factors impacting the treatment landscape of spinal muscular atrophy (SMA).
October 31st 2022
Douglas K Devries, OD, discusses an overview on treatment pathways and burden of disease associated with Demodex blepharitis.
September 1st 2022
Dr David Rosmarin, MD, explores the treatment landscape and clinical burden associated with vitiligo.
August 10th 2022
A discussion series reviewing the differences between unbranded biologics and biosimilars and an overview of payer and provider considerations for decision-making.
This content is a production of Managed Healthcare Executive; distribution of this K-Cast is supported by funding from CSL Behring LLC. CSL Behring LLC was not involved in the creation of the content of this production.
Steven Pipe, MD, discusses the treatment options for patients with hemophilia B, including his hope for future management of the bleeding joint disease.
June 7th 2022
Dr Laura Periman, MD discusses biopsychosocial and economic impacts, as well as innovative treatment opportunities for patients with dry eye disease.
May 20th 2022
Neal Bhatia, MD, discusses atopic dermatitis and the treatment process, as well as how to improve access to therapies for patients with this disease.
December 22nd 2021
Jennifer Brigitte Green, MD, discusses the management of type 2 diabetes for patients not currently controlled on oral antidiabetic medications.
December 10th 2021
Expert hematologist/oncologist David R. Gandara, MD, highlights the value comprehensive genomic profiling has in guiding therapeutic decisions.
June 15th 2021
Recommendations for treating HER2-positive metastatic breast cancer with newer HER2-targeted treatment approaches and considerations regarding their adoption into clinical practice.
